Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioatla, Inc. (BCAB) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bioatla, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1826892.
Total stock buying since 2020: $40,364,983.
Total stock sales since 2020: $46,279,291.
Total stock option exercises since 2020: $139,446.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 148,295 | $335,836 | 0 | $0 | 0 | $0 |
| 2022 | 154,440 | $629,127 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 1,236,742 | $46,279,291 | 7,747 | $139,446 |
| 2020 | 2,188,890 | $39,400,020 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-12 | 81,495 | $172,519 | 0 | $0 | 0 | $0 |
| 2023-09 | 2,000 | $5,080 | 0 | $0 | 0 | $0 |
| 2023-03 | 64,800 | $158,237 | 0 | $0 | 0 | $0 |
| 2022-12 | 3,700 | $30,813 | 0 | $0 | 0 | $0 |
| 2022-11 | 2,000 | $16,540 | 0 | $0 | 0 | $0 |
| 2022-09 | 3,000 | $25,900 | 0 | $0 | 0 | $0 |
| 2022-08 | 26,350 | $206,610 | 0 | $0 | 0 | $0 |
| 2022-06 | 119,390 | $349,264 | 0 | $0 | 0 | $0 |
| 2021-12 | 0 | $0 | 43,628 | $1,001,787 | 0 | $0 |
| 2021-11 | 0 | $0 | 122,540 | $3,063,484 | 0 | $0 |
| 2021-10 | 0 | $0 | 3,586 | $108,345 | 0 | $0 |
| 2021-09 | 0 | $0 | 450 | $16,569 | 0 | $0 |
| 2021-08 | 0 | $0 | 591,819 | $23,494,753 | 7,747 | $139,446 |
| 2021-07 | 0 | $0 | 450 | $17,230 | 0 | $0 |
| 2021-06 | 0 | $0 | 474,269 | $18,577,123 | 0 | $0 |
| 2020-12 | 2,188,890 | $39,400,020 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-26 | Mcbrinn Sylvia (Director) | Buy | 4,000 | 2.33 | 9,320 |
| 2023-12-20 | Short Jay M Phd (Chief Executive Officer) | Buy | 50,000 | 2.14 | 106,900 |
| 2023-12-19 | Vasquez Christian (See Remarks) | Buy | 7,495 | 2.04 | 15,259 |
| 2023-12-19 | Steinman Lawrence (Director) | Buy | 20,000 | 2.05 | 41,040 |
| 2023-09-08 | Mcbrinn Sylvia (Director) | Buy | 2,000 | 2.54 | 5,080 |
| 2023-03-29 | Short Jay M Phd (Chief Executive Officer) | Buy | 40,800 | 2.47 | 100,857 |
| 2023-03-28 | Vasquez Christian (See Remarks) | Buy | 20,000 | 2.40 | 47,980 |
| 2023-03-28 | Mcbrinn Sylvia (Director) | Buy | 4,000 | 2.35 | 9,400 |
| 2022-12-19 | Mcbrinn Sylvia (Director) | Buy | 3,700 | 8.33 | 30,813 |
| 2022-11-22 | Mcbrinn Sylvia (Director) | Buy | 2,000 | 8.27 | 16,540 |
| 2022-09-13 | Mcbrinn Sylvia (Director) | Buy | 1,000 | 8.20 | 8,200 |
| 2022-09-12 | Mcbrinn Sylvia (Director) | Buy | 2,000 | 8.85 | 17,700 |
| 2022-08-12 | Short Jay M Phd (Chief Executive Officer) | Buy | 26,350 | 7.84 | 206,610 |
| 2022-06-22 | Short Jay M Phd (Chief Executive Officer) | Buy | 40,308 | 2.91 | 117,296 |
| 2022-06-21 | Short Jay M Phd (Chief Executive Officer) | Buy | 29,082 | 2.79 | 81,051 |
| 2022-06-09 | Vasquez Christian (See Remarks) | Buy | 10,000 | 2.97 | 29,720 |
| 2022-06-08 | Vasquez Christian (See Remarks) | Buy | 25,848 | 3.02 | 78,190 |
| 2022-06-07 | Vasquez Christian (See Remarks) | Buy | 14,152 | 3.04 | 43,007 |
| 2021-12-02 | Vasquez Christian (See Remarks) | Sale | 200 | 22.11 | 4,421 |
| 2021-12-02 | Sievers Eric (Chief Medical Officer) | Sale | 820 | 22.11 | 18,126 |
| 2021-12-02 | Smith Scott Andrew (President) | Sale | 2,984 | 22.11 | 65,964 |
| 2021-12-02 | Waldron Richard A (Chief Financial Officer) | Sale | 1,434 | 22.11 | 31,700 |
| 2021-12-02 | Short Jay M Phd (Chief Executive Officer) | Sale | 4,811 | 22.11 | 106,351 |
| 2021-12-01 | Vasquez Christian (See Remarks) | Sale | 1,011 | 23.23 | 23,480 |
| 2021-12-01 | Sievers Eric (Chief Medical Officer) | Sale | 173 | 23.23 | 4,017 |
| 2021-12-01 | Smith Scott Andrew (President) | Sale | 628 | 23.23 | 14,585 |
| 2021-12-01 | Waldron Richard A (Chief Financial Officer) | Sale | 7,246 | 23.23 | 168,288 |
| 2021-12-01 | Short Jay M Phd (Chief Executive Officer) | Sale | 24,321 | 23.23 | 564,855 |
| 2021-11-30 | Vasquez Christian (See Remarks) | Sale | 768 | 24.68 | 18,957 |
| 2021-11-30 | Sievers Eric (Chief Medical Officer) | Sale | 131 | 24.68 | 3,233 |
| 2021-11-30 | Smith Scott Andrew (President) | Sale | 478 | 24.68 | 11,798 |
| 2021-11-30 | Waldron Richard A (Chief Financial Officer) | Sale | 5,510 | 24.68 | 136,008 |
| 2021-11-30 | Short Jay M Phd (Chief Executive Officer) | Sale | 18,490 | 24.68 | 456,407 |
| 2021-11-29 | Vasquez Christian (See Remarks) | Sale | 642 | 23.89 | 15,337 |
| 2021-11-29 | Sievers Eric (Chief Medical Officer) | Sale | 110 | 23.89 | 2,627 |
| 2021-11-29 | Smith Scott Andrew (President) | Sale | 399 | 23.89 | 9,532 |
| 2021-11-29 | Waldron Richard A (Chief Financial Officer) | Sale | 4,599 | 23.89 | 109,870 |
| 2021-11-29 | Short Jay M Phd (Chief Executive Officer) | Sale | 15,435 | 23.89 | 368,742 |
| 2021-11-24 | Vasquez Christian (See Remarks) | Sale | 750 | 24.94 | 18,705 |
| 2021-11-24 | Sievers Eric (Chief Medical Officer) | Sale | 129 | 24.94 | 3,217 |
| 2021-11-24 | Smith Scott Andrew (President) | Sale | 466 | 24.94 | 11,622 |
| 2021-11-24 | Waldron Richard A (Chief Financial Officer) | Sale | 3,937 | 24.94 | 98,192 |
| 2021-11-24 | Short Jay M Phd (Chief Executive Officer) | Sale | 17,022 | 24.94 | 424,545 |
| 2021-11-23 | Vasquez Christian (See Remarks) | Sale | 1,100 | 25.16 | 27,676 |
| 2021-11-23 | Sievers Eric (Chief Medical Officer) | Sale | 187 | 25.16 | 4,704 |
| 2021-11-23 | Smith Scott Andrew (President) | Sale | 684 | 25.16 | 17,209 |
| 2021-11-23 | Waldron Richard A (Chief Financial Officer) | Sale | 5,770 | 25.16 | 145,173 |
| 2021-11-23 | Short Jay M Phd (Chief Executive Officer) | Sale | 24,943 | 25.16 | 627,565 |
| 2021-11-22 | Vasquez Christian (See Remarks) | Sale | 691 | 26.23 | 18,128 |
| 2021-11-22 | Sievers Eric (Chief Medical Officer) | Sale | 118 | 26.23 | 3,095 |
| 2021-11-22 | Smith Scott Andrew (President) | Sale | 430 | 26.23 | 11,281 |
| 2021-11-22 | Waldron Richard A (Chief Financial Officer) | Sale | 3,626 | 26.23 | 95,128 |
| 2021-11-22 | Short Jay M Phd (Chief Executive Officer) | Sale | 15,675 | 26.23 | 411,233 |
| 2021-11-02 | Steinman Lawrence (Director) | Sale | 450 | 30.00 | 13,500 |
| 2021-10-01 | Sievers Eric (Chief Medical Officer) | Sale | 592 | 30.39 | 17,993 |
| 2021-10-01 | Smith Scott Andrew (President) | Sale | 2,994 | 30.18 | 90,352 |
| 2021-09-15 | Steinman Lawrence (Director) | Sale | 450 | 36.82 | 16,569 |
| 2021-08-26 | Sievers Eric (Chief Medical Officer) | Sale | 6,883 | 39.59 | 272,497 |
| 2021-08-26 | Smith Scott Andrew (President) | Sale | 33,244 | 40.26 | 1,338,403 |
| 2021-08-24 | Levy Guy (Director) | Sale | 546,709 | 39.65 | 21,677,011 |
| 2021-08-24 | Short Jay M Phd (Chief Executive Officer) | Sale | 4,533 | 41.60 | 188,572 |
| 2021-08-24 | Short Jay M Phd (Chief Executive Officer) | Option Ex | 7,747 | 18.00 | 139,446 |
| 2021-08-16 | Steinman Lawrence (Director) | Sale | 450 | 40.60 | 18,270 |
| 2021-07-15 | Steinman Lawrence (Director) | Sale | 450 | 38.29 | 17,230 |
| 2021-06-21 | Short Jay M Phd (Chief Executive Officer) | Sale | 55,000 | 39.23 | 2,157,375 |
| 2021-06-17 | Levy Guy (Director) | Sale | 400,000 | 39.16 | 15,663,999 |
| 2021-06-17 | Short Jay M Phd (Chief Executive Officer) | Sale | 19,269 | 39.22 | 755,749 |
| 2020-12-18 | Levy Guy (Director) | Buy | 1,388,890 | 18.00 | 25,000,020 |
| 2020-12-18 | Cormorant Private Healthcare Fund Ii, Lp | Buy | 800,000 | 18.00 | 14,400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BCAB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bioatla, Inc. (symbol BCAB, CIK number 1826892) see the Securities and Exchange Commission (SEC) website.